[求文] 求paper兩篇

paulyeh0525 發表於 2021/12/13 上午12:20:34

看板medstudent標題[求文] 求paper兩篇作者

(躺著比你高)時間Dec 13 00:20:34 2021推噓 1 推:1 噓:0 →:0

標題：
Reducing Adenoviral Patient-Infected Days (RAPID) Study: A Randomized Trial Assessing Efficacy of One Time, In-Office Application of 5% Povidone-Iodine in Treatment of Adenoviral Conjunctivitis
出處：
Investigative Ophthalmology & Visual Science July 2019, Vol.60,6257

標題：
Efficacy and safety of dexamethasone/povidone-iodine ophthalmic suspension inadenoviral conjunctivitis
出處：
Investigative Ophthalmology & Visual Science 2017, Vol.58:8

學校的資源找不到，sci-hub也沒有
跪求善心人士幫忙
麻煩寄到： [email protected]

感謝

※ PTT留言評論

※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 223.136.53.248 (臺灣)

※ PTT 網址

推

cheesesteak12/13 10:24這兩篇看起來只是meeting abstract?

其他人也閱讀了

PTT 熱門相關

36
[其他] 小型雙盲實驗顯示, 羥氯喹對武漢肺炎有效
出處: 標題: Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
13
[其他] AZ更新美國第三期臨床數據：保護力約76%
------------------------------------------------------------------------- 1.發文前請先詳閱[其他]分類發文規範，未依規範發文將受處份。 ----------------------------按ctrl+y可刪除以上內容。--------------------- 76% vaccine efficacy against symptomatic COVID-19 100% efficacy against severe or critical disease and hospitalisation
8
Re: [新聞] 智飛疫苗完成三期打3劑保護力逾8成
很好奇地去查了一些相關資料 Clinical Trial 重點 Phase 3 1. Case Number
4
[求文] 徵求Paper 兩篇
各位前輩好，小弟又來徵文了標題一: Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study PMID:35285374
1
[情報] 愛荷華大學電機與電腦工程系(ECE)博士班
大家好目前我們實驗室想招1~2個博士生以下是我本人與實驗室的介紹歡迎有興趣的學弟妹與我聯絡 :) 學校: The University of Iowa 系所: Electrical and Computer Engineering
[求文] 徵一篇paper
代po 徵求一篇paper :One-Year Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Te nsion Glaucoma. 我的醫院沒有收錄，麻煩各位了